PE
EDIT icon

Point72 Europe’s Editas Medicine EDIT Stock Holding History

Point72 Europe’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$13.3K Buy
+3,833
New +$10.7K ﹤0.01% 511

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Point72 Europe's EDIT Position: Q3 2025 in Review

Point72 Europe opened a new position in Editas Medicine (EDIT) in Q3 2025: 3,833 shares worth $13.3K. The stake represents ﹤0.01% of the portfolio and ranks #511 among its holdings.

193 funds tracked by Wall St. Rank hold EDIT as of Q3 2025.

  • Point72 Europe held 3,833 shares of Editas Medicine worth $13.3K as of Q3 2025.
  • Editas Medicine was a new Point72 Europe position in Q3 2025.
  • Editas Medicine made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #511 holding.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.